Copper(I) dicyclohexylamide ([Cu NCy2)] n ; 1), copper(I) 2,2,6,6-tetramethylpiperidide 2,2,6,6-tetramethylpiperidide(I) pyrrolidide ([Cu TMPH8)] n ; 3) were synthesised by a metathesis reaction between copper(I) chloride and the corresponding lithium amide (Route A, Scheme 3).
The signals B, E, H (BNF) as well as G, I, J, N, O (copper sulfate), and M (acridine) were specifically altered for one toxin.
The target used to deposit Cu2O was a 4-N pure copper block mounted on the cathode.
The homogeneous reverse atom transfer radical polymerization (reverse ATRP) of glycidyl methacrylate (GMA) was carried out in bulk, using 2,2′-azobisisobutyronitrile (AIBN) as the initiator and N,N-n-butyldithiocarbamate copper (Cu SC(S N(C4H9 2)2) as the catalyst.
In Lcc9, Lcc13 and Lcc14 in laccase sensu stricto subfamily 2, the conserved histidines and the intermediate tryptophan (His-Trp-His) in the N-terminal copper binding element L1 were missing (indicated as triangles), and the conserved His in L2 has been changed to Gln, and the His in L3 to Asn in Lcc9, 13, and 14 (Fig. 2, indicated as triangles).
LuBGAL22 and LuBGAL24 are over 1300aa in length, and, in the case of LuBGAL24, containing additional N-terminal copper oxidase domains, possibly the result of a gene fusion.
The one exception, LuBGAL24, contained a GH35 domain that started at position 568 of the peptide sequence, and was further distinguished by the presence of three N-terminal copper oxidase domains preceding the GH35 domain.
Eleven studies assessed the effect of copper (N = 7), silver (N = 1), metal-alloy (N = 1), or organosilane-treated surfaces (N = 2) on microbial contamination.
Organometal halide perovskite solar cells have been constructed using soluble tetra-n-butyl-copper phthalocyanine as hole transporting material.
Combination then of tetra-n-butyl-copper phthalocyanine with graphene oxide offers a very good alternative of simpler and stable materials for perovskite solar cell construction.
In this study, the majority of devices that induced uterine perforation were copper-releasing IUDs with T-shaped copper (n = 10) followed by V-shaped copper IUDs (n = 13) and four of those with O-shaped IUDs (Table 1).
